Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Patulin, a Mycotoxin, Has Potent Cytotoxic Activity on Actue Lymphoblastic Leukemia and Induce Apoptosis through Intrinsic and Extrinsic Pathways.

Fengrong Wang, MD, Ebeneier David, PhD, Sagar Lonial, MD, Martha Arellano, MD, Hanna J. Khoury, MD, Amelia Langston, MD, Mary Jo Lechowicz, MD, Ned Waller, MD PhD

Blood (2007) 110 (11): 4334.

https://doi.org/10.1182/blood.V110.11.4334.4334

Published: 2007

Journal Articles

Mechanisms of Migration and Generation of Allo-Reactive Donor T Cells That Cause Organ Specific Acute GvHD in Allogeneic BMT Recipients.

Mohammad S. Hossain, PhD, Ned Waller, MD. Ph.D

Blood (2007) 110 (11): 3270.

https://doi.org/10.1182/blood.V110.11.3270.3270

Published: 2007

Journal Articles

A Mathematical Model of Stochastic Engraftment by Non-Interacting Single Umbilical Cord Blood (UCB) Grafts Predicts Accelerated Engraftment Using Multiple UCB Grafts.

Anthony F. Waller, Fengrong Wang, MD, Ned Waller, MD, PhD

Blood (2007) 110 (11): 2034.

https://doi.org/10.1182/blood.V110.11.2034.2034

Published: 2007

Journal Articles

The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.

Jonathan L. Kaufman, MD, Amanda M. Cook, CCRP, Christopher Flowers, MD, Amelia A. Langston, MD, Sagar Lonial, MD, Mary Jo Lechowicz, MD, H. Jean Khoury, MD, Gary Calandra, MD, Ned Waller, MD, PhD

Blood (2007) 110 (11): 1912.

https://doi.org/10.1182/blood.V110.11.1912.1912

Published: 2007

Journal Articles

Short-Term Ionomycin Exposure Activates Naive Murine T-Cells and Induces a Rapid Phenotypic Shift to Memory T-Cell Status: Potential for Use as a Method To Reduce GvHD Activity of Allogeneic T-Cells.

Mohammad Hossain, PhD, Cynthia R. Giver, PhD, Ned Waller, MD, PhD

Blood (2007) 110 (11): 2182.

https://doi.org/10.1182/blood.V110.11.2182.2182

Published: 2007

Journal Articles

CD34+CXCR4+ Cell Therapy (AMR-001) for Myocardial Infarction: Preliminary Processing and Product Results of a Phase I Dose Escalation Study.

Ned Waller, MD, PhD, Arshed Quyyumi, Douglas Vaughan, Thomas Moss, Wai S. Chan, Robert Preti, Andrew L. Pecora

Blood (2007) 110 (11): 773.

https://doi.org/10.1182/blood.V110.11.773.773

Published: 2007

Journal Articles

Patients Receiving Palifermin in Conjunction with Melphalan 200 Required Fewer Platelet Transfusions: Analysis of a Retrospective Cohort Study.

Donald A. Hutcherson, RPh, Amelia Langston, MD, Cheryl H. Lin, Pharm D, Christopher Flowers, MD, Mary Jo Lechowicz, MD, Ned Waller, MD, Jolynn K. Sessions, Pharm D, Jonathan L. Kaufman, MD, H. Jean Khoury, MD, Sagar Lonial, MD

Blood (2006) 108 (11): 5261.

https://doi.org/10.1182/blood.V108.11.5261.5261

Published: 2006

Journal Articles

A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis.

Kenneth B. Miller, MD, Nelson J. Chao, MD, Hans A. Messner, MD,PhD, Steven C. Goldstein, MD, Vijay Reddy, MD,PhD, William Vaughan, MD, Steven Devine, MD, Scott D. Rowley, MD, Ned Waller, MD,PhD, Marcel Devetten, MD, Gary J. Schiller, MD

Blood (2006) 108 (11): 5369.

https://doi.org/10.1182/blood.V108.11.5369.5369

Published: 2006

Journal Articles

Infliximab for the Treatment of Chronic Graft Versus Host Disease.

Ethan Tolbert, MD, Ned Waller, MD, PhD, H. Jean Khoury, MD, Mary Jo Lechowicz, MD, Christopher Flowers, MD, Sagar Lonial, MD, Laura Vann, Amelia Langston, MD, Jonathan L. Kaufman, MD

Blood (2006) 108 (11): 2889.

https://doi.org/10.1182/blood.V108.11.2889.2889

Published: 2006

Journal Articles

Tolerability and Anti-Leukemic Activity of Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] in Advanced MDS and AML: Interim Analysis of Phase I/II Data.

Sujatha Murali, MD, Elliott F. Winton, MD, Stephanie McMillan, RN, Sagar Lonial, MD, Ned Waller, MD, Leonard Heffner, MD, Christopher Flowers, MD, Jonathan L. Kaufman, MD, Mary Jo Lechowicz, MD, H. Jean Khoury, MD, Amelia Langston, MD

Blood (2006) 108 (11): 1960.

https://doi.org/10.1182/blood.V108.11.1960.1960

Published: 2006

Journal Articles

Homeostatic Expansion of Donor FoxP3+ CD25+CD4+ T Cells in Recipients of CD4+ Cells Depleted Allogeneic Hematopoietic Graft.

Mohammad S. Hossain, PhD, Cynthia R. Giver, Ph.D, Ned Waller, MD.,Ph.D

Blood (2006) 108 (11): 3207.

https://doi.org/10.1182/blood.V108.11.3207.3207

Published: 2006

Journal Articles

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

Sagar Lonial, MD, Stephanie McMillan, Claire Torre, Amelia A. Langston, MD, Ellie Hamilton, Amanda Cook, Christopher Flowers, MD, Jonathan L. Kaufman, MD, Mary Jo Lechowicz, MD, Ned Waller, MD

Blood (2006) 108 (11): 3377.

https://doi.org/10.1182/blood.V108.11.3377.3377

Published: 2006

Journal Articles

T Cell Reconstitution in First 200 Days Post Transplantation Predicts Long Term Survival in Allogeneic Hematopoetic Progenitor Cell Transplantation (HPCT).

Laura Vann, Milcah Larks, MD, Christopher Flowers, MD, Sagar Lonial, MD, Jonathan Kaufman, MD, Mary Jo Lechowicz, MD, Amelia A. Langston, MD, Jean Khoury, MD, Ned Waller, MD,PhD

Blood (2006) 108 (11): 3224.

https://doi.org/10.1182/blood.V108.11.3224.3224

Published: 2006

Journal Articles

Deep Venous Thromboses Associated with Peripherally Inserted Central Catheters in Patients with Hematological Malignancies.

Ha Tran, MD, Abbas Chamsuddin, MD, Elliott F. Winton, MD, Leonard Heffner, MD, Amelia Langston, MD, Ned Waller, MD, Martha Arellano, MD, H. Jean Khoury, MD

Blood (2006) 108 (11): 4587.

https://doi.org/10.1182/blood.V108.11.4587.4587

Published: 2006

Journal Articles

Impact of Revised International Working Group Criteria on Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Amy S. Lucas, MD, Christopher Flowers, MD, Amelia Langston, MD, Sagar Lonial, MD, Mary Jo Lechowicz, MD, Ned Waller, MD, Jonathan L. Kaufman, MD, H. Jean Khoury, MD

Blood (2006) 108 (11): 3065.

https://doi.org/10.1182/blood.V108.11.3065.3065

Published: 2006

Journal Articles

Donor DC Subsets Polarize Donor T-Cell Immune Responses in Allogeneic BMT.

Jian-Ming Li, PhD, Cynthia Giver, PhD, Doug McMillan, PhD, Wayne Harris, BS, David L. Jaye, MD, Ned Waller, MD, PhD

Blood (2005) 106 (11): 573.

https://doi.org/10.1182/blood.V106.11.573.573

Published: 2005

Journal Articles

Injection of Blastocysts from Immunocompetent Mice with Human HPC Having High ALDH Activity Results in Chimeric Animals with Low-Level Human Contribution in Hematopoietic and Non-Hematopoietic Tissues.

Cynthia R. Giver, PhD, Sandra J. Foster, PhD, William D. Martin, PhD, Andrew E. Balber, PhD, Ned Waller, MD, PhD

Blood (2004) 104 (11): 3224.

https://doi.org/10.1182/blood.V104.11.3224.3224

Published: 2004

NARROW

Patulin, a Mycotoxin, Has Potent Cytotoxic Activity on Actue Lymphoblastic Leukemia and Induce Apoptosis through Intrinsic and Extrinsic Pathways.

Mechanisms of Migration and Generation of Allo-Reactive Donor T Cells That Cause Organ Specific Acute GvHD in Allogeneic BMT Recipients.

A Mathematical Model of Stochastic Engraftment by Non-Interacting Single Umbilical Cord Blood (UCB) Grafts Predicts Accelerated Engraftment Using Multiple UCB Grafts.

The Effect of Rituximab on Mobilization with AMD3100 Plus G-CSF in Patients with Relapsed or Refractory NHL or HD.

Short-Term Ionomycin Exposure Activates Naive Murine T-Cells and Induces a Rapid Phenotypic Shift to Memory T-Cell Status: Potential for Use as a Method To Reduce GvHD Activity of Allogeneic T-Cells.

CD34+CXCR4+ Cell Therapy (AMR-001) for Myocardial Infarction: Preliminary Processing and Product Results of a Phase I Dose Escalation Study.

Patients Receiving Palifermin in Conjunction with Melphalan 200 Required Fewer Platelet Transfusions: Analysis of a Retrospective Cohort Study.

A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis.

Infliximab for the Treatment of Chronic Graft Versus Host Disease.

Tolerability and Anti-Leukemic Activity of Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] in Advanced MDS and AML: Interim Analysis of Phase I/II Data.

Homeostatic Expansion of Donor FoxP3+ CD25+CD4+ T Cells in Recipients of CD4+ Cells Depleted Allogeneic Hematopoietic Graft.

A Randomized Trial To Evaluate the Impact of Cytokines (G-CSF or GM + G-CSF) on Dendritic Cell and T-Cell Content and Function When Mobilizing Normal Donors for Allogeneic Progenitor Cell Transplant.

T Cell Reconstitution in First 200 Days Post Transplantation Predicts Long Term Survival in Allogeneic Hematopoetic Progenitor Cell Transplantation (HPCT).

Deep Venous Thromboses Associated with Peripherally Inserted Central Catheters in Patients with Hematological Malignancies.

Impact of Revised International Working Group Criteria on Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

Donor DC Subsets Polarize Donor T-Cell Immune Responses in Allogeneic BMT.

Injection of Blastocysts from Immunocompetent Mice with Human HPC Having High ALDH Activity Results in Chimeric Animals with Low-Level Human Contribution in Hematopoietic and Non-Hematopoietic Tissues.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only